What does FIGO use for staging corpus uteri cancer?

The correct approach for staging corpus uteri cancer according to FIGO (International Federation of Gynecology and Obstetrics) is indeed surgical/pathologic staging. This method primarily involves assessing the tumor after surgical intervention, where the extent of disease can be more accurately evaluated through histopathological examination of the tissue obtained during surgery.

During surgical staging, the physician is able to determine how far the cancer has spread within the uterus and to other structures, which is crucial for proper staging and subsequent treatment planning. This emphasis on surgical findings enhances the reliability of the staging process compared to methods relying solely on imaging or clinical evaluations, as those may not provide a complete or definitive picture of the disease’s progression.

Other choices, like radiological findings, palliative care assessment, or clinical evaluation only, do not offer the comprehensive insight needed for accurate cancer staging as provided by surgical/pathologic evaluation.